Organ specific upregulation of several target genes such as Akt2, ATM, and Trp53 was seen with the GHRH antagonist. In the animals pretreated with JMR-132 the small intestine and the kidney showed higher average vessel count. Conclusion Pretreatment with GHRH antagonist JMR-132 protects at ...